TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region

Bladder cancer (BC) is the 10th most common cancer in the world. While there are FDA-approved urinary assays to detect BC, none have demonstrated sufficient sensitivity and specificity to be integrated into clinical practice. Telomerase Reverse Transcriptase (TERT) gene mutations have been identifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Pakmanesh, Hamid, Anvari, Omid, Forey, Nathalie, Weiderpass, Elisabete, Malekpourafshar, Reza, Iranpour, Maryam, Shahesmaeili, Armita, Ahmadi, Nahid, Bazrafshan, Azam, Zendehdel, Kazem, Kannengiesser, Caroline, Ba, Ibrahima, McKay, James, Zvereva, Maria, Hosen, Md Ismail, Sheikh, Mahdi, Calvez-Kelm, Florence Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696845/
https://www.ncbi.nlm.nih.gov/pubmed/36430798
http://dx.doi.org/10.3390/ijms232214319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696845/
https://www.ncbi.nlm.nih.gov/pubmed/36430798
http://dx.doi.org/10.3390/ijms232214319

Ejemplares similares